(lp0
S"Horizon Pharma plc to Present Data on RAVICTI  Oral ... GlobeNewswire  - 17 hours ago DUBLIN, Ireland, March 22, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p1
aS"Horizon Pharma plc Announces &quot;UCD in Common&quot; for the Urea Cycle Disorder (UCD ... GlobeNewswire  - Mar 16, 2017 DUBLIN, Ireland, March 16, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;...Putnam Investments LLC Has $2243000 Position in Horizon Pharma PLC  - The Cerbat Gem"
p2
aS"Horizon Pharma plc Launches RAREis Campaign Elevating Faces of the Rare ... GlobeNewswire  - Feb 28, 2017 DUBLIN, Ireland, Feb. 28, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p3
aS"Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on ... GlobeNewswire  - Jan 27, 2017 DUBLIN, Ireland, Jan. 27, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p4
aS"Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care ... GlobeNewswire  - Feb 14, 2017 DUBLIN, Ireland, Feb. 14, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p5
aS"Horizon Pharma plc Announces Topline Results from Phase 3 Study of ACTIMMUNE ... GlobeNewswire  - Dec 8, 2016 DUBLIN, Ireland, Dec. 08, 2016  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;...Down 22%, Is Horizon Pharma plc Stock a Bad-News Buy? - Motley FoolHorizon Pharma aborts key Actimmune trial; shares plunge - Reuters"
p6
aS"Horizon Pharma plc Announces Urea Cycle Disorders Medical Foods and ... GlobeNewswire  - Mar 2, 2017 DUBLIN, Ireland, March 02, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p7
aS'Global Genes and Horizon Pharma plc Partner to Offer Nephropathic Cystinosis ... PR Newswire  - Jan 17, 2017 17, 2017 /PRNewswire-USNewswire/ -- Global Genes and Horizon Pharma plc  announced the Horizon Nephropathic Cystinosis Scholarship , an exclusive opportunity for people living with nephropathic cystinosis to further their&nbsp;...Rare Disease College Report: Nephropathic Cystinosis Scholarships Available - Rare Disease Report'
p8
aS"Unusual Volume Spikes For: Horizon Pharma plc  HugoPress - 17 hours ago Mizuho Upgrades Horizon Pharma plc 's stock to Buy with the price target of $25. This rating was issued on 12/16/16.Horizon Pharma PLC  Given Average Rating of Buy by Brokerages - Chaffey BreezeHorizon Pharma plc  Stock current Trends Analysis - TopChronicle"
p9
aS'Horizon Pharma plc  Moves Lower on Volume Spike for March 07 Equities.com - Mar 7, 2017 Horizon Pharma plc  traded on unusually high volume on Mar. 07, as the stock lost 3.42% to close at $14.97. On the day, Horizon Pharma plc saw 5.56 million shares trade hands on 33,005 trades. Considering that the stock averages only a daily&nbsp;...Horizon Pharma plc  Quarterly EPS At $0.84 - Stock ObserverHorizon Pharma PLC  PT Lowered to $22.00 - Chaffey Breeze'
p10
a.